Please login to the form below

Not currently logged in
Email:
Password:

Polyhedra appoints Steve Hobbs chief business development officer

He joins the group from Apodi

Steve HobbsThe Polyhedra Group has appointed Steve Hobbs as chief business development officer.

He joins the group, which produces secure codes for pharmaceutical packs which patients and healthcare professionals can scan with their smartphone to access resources, from Apodi.

While at Apodi he served as part of its senior management team as director of business and partnership development, having previously founded Australian corporate advisory firm Achieve Capital.

He brings to Polyheda over 30 years international experience in pharmaceuticals and healthcare, gained at firms such as Boehringer Mannheim, Servier Laboratories and Innovex UK, the latter of which saw Hobbs launch launching Innovex in Australia.


15th April 2014

From: Sales, Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....